Highlights
Feb 2006
- Science Perspectives Article Promotes a Vision for Integrated Bioenergy Future
- Publication shows value of Cryopreserved Mutant Mouse Bank
- Proteome of Rhodopseudomonas palustris Shows Metabolic Diversity and Regulation
Scientists can study the biological impacts of engineered nanomaterials on cells within the body with greater resolution than ever because of a procedure developed by researchers at the Department of Energy's Oak Ridge National Laboratory.
A Company, NellOne Therapeutics, has been formed through Battelle Ventures to research the potential for a new therapy that could help heart patients, according to Oak Ridge National Laboratory scientist Cymbeline Culiat.